Page last updated: 2024-11-05

n,n-diethylacetamide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID12703
CHEMBL ID3184758
SCHEMBL ID18738
MeSH IDM0101893

Synonyms (48)

Synonym
6yo81d7st6 ,
n,n-diaethylacetamid
4-04-00-00349 (beilstein handbook reference)
unii-6yo81d7st6
diethylacetamide
acetic acid, amide, n,n-diethyl
ai3-02182
nsc 101
einecs 211-685-2
brn 1209428
n,n-diaethylacetamid [german]
hsdb 5513
inchi=1/c6h13no/c1-4-7(5-2)6(3)8/h4-5h2,1-3h
acetamide, n,n-diethyl-
nsc-101
685-91-6
n,n-diethylacetamide
nsc101
wln: 2n2&v1
n,n-diethylacetamide, 97%
n-acetyldiethylamine ,
D0461
AKOS003862095
NCGC00248816-01
cas-685-91-6
dtxsid9020459 ,
dtxcid10459
tox21_200733
NCGC00258287-01
n,n-diethyl-acetamide
FT-0629458
n,n-diethylacetamide [hsdb]
SCHEMBL18738
n,n-di ethylacetamide
n,n-diethylethanamide
ch3con(c2h5)2
acetic acid diethylamide
CHEMBL3184758
mfcd00009047
H11276
DS-3397
n,n-diethyl acetamide
EN300-107551
SY037752
n-diethylacetamide
Q27265731
n.n-diethyl acetamide
CS-W009545
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (3)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
GLI family zinc finger 3Homo sapiens (human)Potency50.78830.000714.592883.7951AID1259369
retinoid X nuclear receptor alphaHomo sapiens (human)Potency3.13220.000817.505159.3239AID1159527; AID1159531
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_aHomo sapiens (human)Potency57.518719.739145.978464.9432AID1159509
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (71.43)18.7374
1990's1 (14.29)18.2507
2000's0 (0.00)29.6817
2010's1 (14.29)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 31.62

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index31.62 (24.57)
Research Supply Index2.20 (2.92)
Research Growth Index4.14 (4.65)
Search Engine Demand Index39.34 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (31.62)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other8 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]